Formulation and Evaluation Combination of Anti-inflammation and Skeletal muscle relaxant gel.

This study focuses on developing a topical gel formulation that combines a nonsteroidal anti-inflammatory drug (NSAID) and a muscle relaxant to manage musculoskeletal pain and inflammation. The gel's physicochemical properties, including spreadability, pH, and viscosity, were evaluated to ensure optimal performance. The solution showed good spreadability, an ideal viscosity for user-friendliness, and a pH appropriate for skin application. In investigations on skin irritation, there were few negative reactions, suggesting acceptable tolerance. A topical gel containing NSAID and muscle relaxant offers a promising treatment option for musculoskeletal disorders by reducing systemic adverse effects and reducing localised pain. There may be clinical uses for this formulation in the treatment of ailments like sports injuries, muscle spasms, and lower back discomfort. The created gel composition offers patients with musculoskeletal pain and inflammation a practical and efficient therapeutic choice. Systemic exposure and any adverse effects are reduced by the gel's direct delivery of the active components to the site of action. The clinical efficacy and safety of this formulation need to be investigated further.